Two wind turbines in Cork’s lower harbour that will support the manufacturing operations of DePuy Synthes and Janssen Biologics have gone live. They will reduce the environmental impacts of both plants and reduce energy costs by 30pc.
This follows a series of recent announcements by Johnson & Johnson in Ireland including the investment of €80 million and the creation of 270 jobs at the company’s new Ethicon Biosurgery manufacturing facility in Limerick in April.
“Wind energy will safeguard jobs, provide security of energy supply, help Ireland meet its EU carbon reduction targets and reduce our dependence on expensive fossil fuels,” Minister for Research and Innovation Seán Sherlock said.
The wind turbine project is the outcome of an unique collaboration between Johnson & Johnson, GSK and Novartis – the Cork Lower Harbour Energy Group.
Collectively, the four companies are responsible for the employment of over 4,000 people in Ireland and have invested more than €2 billion in the Cork area over the last twenty years.
“As the world’s largest health care company, all of us at Johnson & Johnson recognise the critical interdependence between human health and the health of our planet,” explained William Appelo, vice president in charge of Supply Chain, Global Orthopeadics Group at Johnson & Johnson.
“We are committed to minimising environmental impacts across our operations.”
